Effects of synthetic form of tracheal antimicrobial peptide on respiratory pathogens

The Journal of Antimicrobial Chemotherapy
C LawyerK Watabe

Abstract

We have synthesized a C-terminal portion of tracheal antimicrobial peptide (TAP) with 38 amino acids and tested it for efficacy on various clinical isolates of Pseudomonas aeruginosa strains from patients with cystic fibrosis and also on Aspergillus fumigatus. Our results indicate that the synthetic TAP has both potent bactericidal and fungicidal activities and that a combination of TAP and amphotericin B showed strong additive effects of growth inhibition on A fumigatus. These results suggest that TAP is potentially an effective therapy for Aspergillus and multi-drug-resistant Pseudomonas, pathogens that are often a serious threat to patients with cystic fibrosis.

Citations

Jun 25, 1999·The Journal of Antimicrobial Chemotherapy·P M Bennett
Feb 5, 2002·Annual Review of Physiology·Brian C Schutte, Paul B McCray
Jun 15, 1999·Pediatric Research·K M Huttner, C L Bevins
Apr 8, 2015·Pharmaceuticals·Babatunji Emmanuel OyinloyeAbidemi Paul Kappo
Jul 2, 2005·Expert Opinion on Emerging Drugs·Sevtap Arikan, John H Rex
Jan 22, 2013·Veterinary Immunology and Immunopathology·Khaled Taha-AbdelazizJeff L Caswell
Mar 19, 2016·Veterinary Research·Khaled Taha-AbdelazizJeff L Caswell
Jun 17, 2010·Journal of Peptide Science : an Official Publication of the European Peptide Society·Suresh Yenugu, Ganapathy Narmadha
Jun 14, 2015·Transgenic Research·Max SchubertGreta Nölke
Dec 31, 1998·Antimicrobial Agents and Chemotherapy·A J De Lucca, T J Walsh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.